Cargando…
Pharmacogenetics aspects of oral anticoagulants therapy
Rationale: Vitamin K antagonists (VKA), such as warfarin and acenocoumarol, are widely used for the prevention and treatment of thromboembolic diseases and they are some of the most commonly prescribed types of medications. They are characterized by narrow therapeutic indices and inter-individual or...
Autores principales: | Militaru, FC, Vesa, SC, Pop, TR, Buzoianu, AD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392103/ https://www.ncbi.nlm.nih.gov/pubmed/25866574 |
Ejemplares similares
-
Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010) -
Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review
por: Raymond, Johanna, et al.
Publicado: (2021) -
Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018) -
Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021) -
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
por: Roguljić, Hrvoje, et al.
Publicado: (2022)